Aytu Biopharma (AYTU) Research & Development (2014 - 2025)
Aytu Biopharma (AYTU) posted quarterly Research & Development of $6.0 million for Q4 2025, up 13.77% year-over-year from $5.3 million in Q4 2024, and up 12.7% quarter-over-quarter from $5.3 million in Q3 2025.
Aytu Biopharma (AYTU) Research & Development (2014 - 2025) Analysis & Trends
Aytu Biopharma (AYTU) has reported Research & Development for 12 consecutive years, with $6.0 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Research & Development rose 13.77% year-over-year to $6.0 million; the TTM figure through Mar 2026 stood at -$3.5 million (down 121.33% YoY), while the FY2025 annual figure was $1.3 million, down 94.0% from the prior year.
- Research & Development advanced to $6.0 million in Q4 2025 per AYTU's latest filing, from $5.3 million in the prior quarter.
- Across five years, Research & Development topped out at $29.4 million in Q2 2021 and bottomed at -$14.8 million in Q2 2025.
- Historically, Research & Development has averaged $6.2 million across 5 years, with a median of $5.3 million in 2024.
- Annual changes were most pronounced in 2021 — Research & Development surged 4980.33% — and 2025, when it tumbled 372.94%.
- Aytu Biopharma's Research & Development stood at $9.7 million in 2021, then slumped by 82.3% to $1.7 million in 2022, then tumbled by 69.53% to $521000.0 in 2023, then soared by 911.9% to $5.3 million in 2024, then grew by 13.77% to $6.0 million in 2025.
- Business Quant data shows AYTU's Research & Development at $6.0 million in Q4 2025, $5.3 million in Q3 2025, and -$14.8 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 970.00 Mn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | -1.05 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 146.30 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 248.30 Mn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 326.70 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 92.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Aytu Biopharma | 24.86 Mn | -1.86 Mn | 7.60 Mn | 5.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.00 Mn |
| Sep 30, 2025 | 5.32 Mn |
| Jun 30, 2025 | -14.80 Mn |
| Mar 31, 2025 | 5.19 Mn |
| Dec 31, 2024 | 5.27 Mn |
| Sep 30, 2024 | 426,000.00 |
| Jun 30, 2024 | 5.42 Mn |
| Mar 31, 2024 | 611,000.00 |
| Dec 31, 2023 | 521,000.00 |
| Sep 30, 2023 | 595,000.00 |
| Jun 30, 2023 | 465,000.00 |
| Mar 31, 2023 | 12.80 Mn |
| Dec 31, 2022 | 1.71 Mn |
| Sep 30, 2022 | 1.06 Mn |
| Jun 30, 2022 | 29.30 Mn |
| Mar 31, 2022 | 9.74 Mn |
| Dec 31, 2021 | 9.66 Mn |
| Sep 30, 2021 | 9.30 Mn |
| Jun 30, 2021 | 29.45 Mn |
| Dec 31, 2020 | 5.71 Mn |